Foundation for innovation
in Cardiometabolism and Nutrition

Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH

Journal of Hepatology

Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH

Restez en contact

Recevez toute l’actualité de la fondation ICAN

This field is for validation purposes and should be left unchanged.

Nos fondateurs

CERTIFIÉ ISO 9001

Nos soutiens institutionnels

Notre réseau